Fact CheckerSign in

NCT06377150Completed

ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study

Source: ClinicalTrials.gov · Last updated 29 Jun 2025

Brief summary (registry, in English)

Retrospective chart review study to elucidate the phenotype and genotype of children with ABCA4-associated Stargardt disease.

Status (registry)
Completed
Study type
Observational
Enrollment
39 (actual)
First submitted
12 Apr 2024
Start date
Apr 2022
Primary completion date
Mar 2024
Lead sponsor
University Hospital Tuebingen
NCT number
NCT06377150

What you commit to

  • Study type: Observational
  • Participants enrolled: 39
  • From Apr 2022 to the primary completion date, Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • 18 years old and older

Who the study is looking for

  • genetically confirmed ABCA4-associated inherited retinal dystrophy

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Tuebingen
Coordinator of this site? Confirm its status
TübingenGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.